BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37365056)

  • 1. Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.
    Shen J; Zhou Y; Yu B; Zhao K; Ding Y
    Eur J Surg Oncol; 2023 Oct; 49(10):106966. PubMed ID: 37365056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
    Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
    BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of web
    Zhan G; Cao P; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a Prognostic Nomogram for Cancer-Specific Survival in Patients With Base-of-Tongue Squamous Cell Carcinoma: A Retrospective Study Based on the SEER Database.
    Lin ZJ; Huang L; Lin YM; Luo R; Wang SC; Lyu J; Shao J
    Cancer Control; 2023; 30():10732748231210733. PubMed ID: 37969067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.
    Huang G; Lin Q; Yin P; Mao K; Zhang J
    Cancer Med; 2023 Jun; 12(12):13167-13181. PubMed ID: 37102245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
    Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
    Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
    J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database.
    Yang D; Zhu M; Xiong X; Su Y; Zhao F; Hu Y; Zhang G; Pei J; Ding Y
    Front Oncol; 2022; 12():987603. PubMed ID: 36185206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
    Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
    BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
    BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of prognostic nomogram based on log odds of positive lymph nodes for patients with gastric signet ring cell carcinoma.
    Xu Z; Jing J; Ma G
    Chin J Cancer Res; 2020 Dec; 32(6):778-793. PubMed ID: 33447000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
    Li S; Liu X; Chen X
    BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
    Zuo H; Li MM
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer.
    Cao R; Jiang H; Liang G; Zhang W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12033-12045. PubMed ID: 37421456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Practical Nomogram and Risk Stratification System Predicting the Cancer-Specific Survival for Patients With Advanced Hepatocellular Carcinoma.
    Yang D; Su Y; Zhao F; Chen C; Zhao K; Xiong X; Ding Y
    Front Oncol; 2022; 12():914192. PubMed ID: 35903694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
    Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
    Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.
    Zeng Q; Yao Y; Zhao M
    BMC Ophthalmol; 2021 May; 21(1):230. PubMed ID: 34030647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
    Zhang K; Tao C; Wu F; Wu J; Rong W
    Ann Palliat Med; 2021 Apr; 10(4):3847-3863. PubMed ID: 33752423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.